Concepts (274)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Laryngeal Diseases | 12 | 2023 | 243 | 4.500 |
Why?
|
| Vocal Cords | 21 | 2023 | 522 | 4.480 |
Why?
|
| Esophageal pH Monitoring | 16 | 2024 | 201 | 3.020 |
Why?
|
| Voice Disorders | 8 | 2019 | 286 | 2.170 |
Why?
|
| Larynx | 5 | 2023 | 492 | 1.960 |
Why?
|
| Voice Quality | 9 | 2024 | 226 | 1.810 |
Why?
|
| Proton Pump Inhibitors | 10 | 2024 | 529 | 1.730 |
Why?
|
| Nonlinear Dynamics | 7 | 2010 | 493 | 1.680 |
Why?
|
| Otolaryngology | 8 | 2021 | 685 | 1.370 |
Why?
|
| Carboxymethylcellulose Sodium | 3 | 2018 | 38 | 1.360 |
Why?
|
| Dysphonia | 6 | 2021 | 144 | 1.250 |
Why?
|
| Silk | 2 | 2018 | 90 | 1.210 |
Why?
|
| Phonation | 3 | 2018 | 220 | 1.120 |
Why?
|
| Stroboscopy | 5 | 2019 | 62 | 1.110 |
Why?
|
| Oscillometry | 4 | 2009 | 145 | 1.060 |
Why?
|
| Durapatite | 3 | 2018 | 163 | 1.060 |
Why?
|
| Vocal Cord Paralysis | 5 | 2019 | 272 | 1.010 |
Why?
|
| Electric Impedance | 11 | 2023 | 754 | 1.010 |
Why?
|
| Pharynx | 5 | 2022 | 432 | 1.000 |
Why?
|
| Glottis | 3 | 2011 | 214 | 0.980 |
Why?
|
| Jaundice, Chronic Idiopathic | 1 | 2022 | 3 | 0.830 |
Why?
|
| Airway Obstruction | 3 | 2023 | 661 | 0.810 |
Why?
|
| Voice | 2 | 2024 | 268 | 0.780 |
Why?
|
| Jaundice | 1 | 2022 | 97 | 0.770 |
Why?
|
| Signal Processing, Computer-Assisted | 5 | 2010 | 1489 | 0.760 |
Why?
|
| Manometry | 5 | 2021 | 453 | 0.690 |
Why?
|
| Laryngeal Neoplasms | 2 | 2020 | 514 | 0.680 |
Why?
|
| Music | 2 | 2020 | 245 | 0.640 |
Why?
|
| Histiocytosis, Langerhans-Cell | 1 | 2020 | 169 | 0.630 |
Why?
|
| Injections | 6 | 2018 | 830 | 0.630 |
Why?
|
| Laser Therapy | 2 | 2022 | 1089 | 0.610 |
Why?
|
| Anti-Ulcer Agents | 1 | 2017 | 112 | 0.550 |
Why?
|
| Esophagus | 3 | 2021 | 1023 | 0.550 |
Why?
|
| Omeprazole | 2 | 2017 | 105 | 0.540 |
Why?
|
| Laryngoscopy | 5 | 2022 | 705 | 0.520 |
Why?
|
| Electrodes | 1 | 2018 | 613 | 0.520 |
Why?
|
| Fundoplication | 1 | 2016 | 144 | 0.500 |
Why?
|
| Hyaluronic Acid | 1 | 2018 | 482 | 0.500 |
Why?
|
| Radar | 2 | 2009 | 11 | 0.400 |
Why?
|
| Biocompatible Materials | 2 | 2018 | 1688 | 0.400 |
Why?
|
| Cicatrix | 1 | 2017 | 781 | 0.390 |
Why?
|
| Cardiomyopathy, Hypertrophic | 1 | 2020 | 1309 | 0.380 |
Why?
|
| Granuloma, Laryngeal | 1 | 2010 | 8 | 0.350 |
Why?
|
| Gout | 1 | 2017 | 618 | 0.340 |
Why?
|
| Algorithms | 5 | 2017 | 13959 | 0.330 |
Why?
|
| Gelatin Sponge, Absorbable | 1 | 2009 | 55 | 0.330 |
Why?
|
| Adipose Tissue | 2 | 2018 | 3299 | 0.330 |
Why?
|
| Gastrointestinal Agents | 1 | 2014 | 508 | 0.330 |
Why?
|
| Dysarthria | 1 | 2009 | 58 | 0.330 |
Why?
|
| Models, Statistical | 5 | 2010 | 5070 | 0.310 |
Why?
|
| Patient Selection | 2 | 2016 | 4244 | 0.280 |
Why?
|
| Artifacts | 2 | 2005 | 1897 | 0.280 |
Why?
|
| Humans | 64 | 2024 | 758381 | 0.270 |
Why?
|
| Atrophy | 4 | 2018 | 1627 | 0.270 |
Why?
|
| Hydrogen-Ion Concentration | 3 | 2021 | 2497 | 0.270 |
Why?
|
| Quality of Life | 4 | 2022 | 13286 | 0.250 |
Why?
|
| Evidence-Based Medicine | 1 | 2017 | 3671 | 0.250 |
Why?
|
| Laryngeal Muscles | 2 | 2018 | 107 | 0.240 |
Why?
|
| Hypopharynx | 4 | 2021 | 53 | 0.240 |
Why?
|
| Laser-Doppler Flowmetry | 1 | 2005 | 239 | 0.240 |
Why?
|
| Office Visits | 1 | 2009 | 596 | 0.240 |
Why?
|
| Severity of Illness Index | 4 | 2021 | 15785 | 0.240 |
Why?
|
| Cost-Benefit Analysis | 1 | 2017 | 5484 | 0.230 |
Why?
|
| Oxides | 1 | 2005 | 401 | 0.220 |
Why?
|
| Electromagnetic Fields | 1 | 2005 | 296 | 0.220 |
Why?
|
| Disease Management | 1 | 2014 | 2500 | 0.220 |
Why?
|
| Aged, 80 and over | 11 | 2020 | 58681 | 0.220 |
Why?
|
| Pattern Recognition, Automated | 1 | 2009 | 994 | 0.210 |
Why?
|
| Disability Evaluation | 3 | 2019 | 1825 | 0.210 |
Why?
|
| Computer Simulation | 4 | 2009 | 6201 | 0.210 |
Why?
|
| Middle Aged | 23 | 2022 | 219560 | 0.210 |
Why?
|
| Dyspnea | 2 | 2020 | 1344 | 0.210 |
Why?
|
| Male | 31 | 2022 | 358742 | 0.210 |
Why?
|
| Retrospective Studies | 14 | 2022 | 80170 | 0.200 |
Why?
|
| Surgical Instruments | 1 | 2005 | 385 | 0.200 |
Why?
|
| Optical Fibers | 1 | 2022 | 135 | 0.200 |
Why?
|
| Otorhinolaryngologic Surgical Procedures | 1 | 2005 | 323 | 0.190 |
Why?
|
| Aged | 20 | 2021 | 168217 | 0.190 |
Why?
|
| Swallows | 1 | 2020 | 4 | 0.190 |
Why?
|
| Metals | 1 | 2005 | 717 | 0.180 |
Why?
|
| Diagnosis, Differential | 4 | 2020 | 12951 | 0.180 |
Why?
|
| Collagen | 1 | 2009 | 2635 | 0.180 |
Why?
|
| Leukoplakia | 1 | 2020 | 18 | 0.180 |
Why?
|
| Laryngitis | 1 | 2020 | 27 | 0.180 |
Why?
|
| Liver Function Tests | 1 | 2022 | 523 | 0.180 |
Why?
|
| Pilot Projects | 4 | 2024 | 8554 | 0.180 |
Why?
|
| Adult | 22 | 2022 | 219916 | 0.180 |
Why?
|
| Esophageal Motility Disorders | 1 | 2021 | 48 | 0.180 |
Why?
|
| Hoarseness | 1 | 2020 | 62 | 0.180 |
Why?
|
| Esophagitis, Peptic | 1 | 2021 | 76 | 0.180 |
Why?
|
| Bilirubin | 1 | 2022 | 437 | 0.170 |
Why?
|
| Hernia, Hiatal | 1 | 2021 | 90 | 0.170 |
Why?
|
| Papilloma | 1 | 2020 | 141 | 0.170 |
Why?
|
| Otorhinolaryngologic Diseases | 1 | 2019 | 95 | 0.160 |
Why?
|
| Delphi Technique | 4 | 2023 | 829 | 0.160 |
Why?
|
| Female | 29 | 2022 | 390316 | 0.150 |
Why?
|
| Laryngostenosis | 1 | 2020 | 167 | 0.150 |
Why?
|
| Occupational Diseases | 1 | 2006 | 1486 | 0.150 |
Why?
|
| Pharyngeal Diseases | 1 | 2019 | 134 | 0.150 |
Why?
|
| Granuloma | 1 | 2020 | 327 | 0.150 |
Why?
|
| Ranitidine | 1 | 2017 | 34 | 0.150 |
Why?
|
| Recovery of Function | 2 | 2018 | 2971 | 0.150 |
Why?
|
| Injections, Intramuscular | 1 | 2018 | 553 | 0.140 |
Why?
|
| Endoscopy | 3 | 2024 | 1834 | 0.140 |
Why?
|
| Deglutition Disorders | 1 | 2023 | 625 | 0.140 |
Why?
|
| Consensus | 2 | 2024 | 3099 | 0.140 |
Why?
|
| Hemorrhage | 1 | 2009 | 3400 | 0.140 |
Why?
|
| Time Factors | 8 | 2020 | 39873 | 0.140 |
Why?
|
| Muscle Contraction | 1 | 2021 | 1196 | 0.140 |
Why?
|
| Transplantation, Autologous | 2 | 2018 | 2114 | 0.130 |
Why?
|
| Medical History Taking | 1 | 2019 | 772 | 0.130 |
Why?
|
| Efficiency, Organizational | 1 | 2020 | 696 | 0.130 |
Why?
|
| Treatment Outcome | 6 | 2020 | 64379 | 0.130 |
Why?
|
| Reproducibility of Results | 4 | 2024 | 20052 | 0.120 |
Why?
|
| Systems Theory | 2 | 2005 | 57 | 0.120 |
Why?
|
| Semiconductors | 2 | 2005 | 99 | 0.120 |
Why?
|
| Ambulatory Care Facilities | 1 | 2020 | 927 | 0.120 |
Why?
|
| Systems Analysis | 2 | 2005 | 169 | 0.110 |
Why?
|
| Clonal Anergy | 1 | 2014 | 171 | 0.110 |
Why?
|
| Publishing | 1 | 2021 | 833 | 0.110 |
Why?
|
| Dogs | 1 | 2018 | 3838 | 0.110 |
Why?
|
| Voice Training | 1 | 2014 | 44 | 0.110 |
Why?
|
| Cafe-au-Lait Spots | 1 | 2013 | 19 | 0.110 |
Why?
|
| Exercise Test | 1 | 2020 | 2121 | 0.110 |
Why?
|
| Swine | 2 | 2018 | 5892 | 0.110 |
Why?
|
| Nerve Net | 1 | 2005 | 2263 | 0.110 |
Why?
|
| Antigens, Plant | 1 | 2012 | 104 | 0.100 |
Why?
|
| Computers | 2 | 2005 | 596 | 0.100 |
Why?
|
| Models, Animal | 1 | 2018 | 2112 | 0.100 |
Why?
|
| Hemoglobinometry | 1 | 2011 | 35 | 0.100 |
Why?
|
| Follow-Up Studies | 6 | 2019 | 39060 | 0.100 |
Why?
|
| Blastocyst | 1 | 2015 | 433 | 0.100 |
Why?
|
| Humidity | 1 | 2013 | 205 | 0.100 |
Why?
|
| Tissue Scaffolds | 1 | 2018 | 926 | 0.090 |
Why?
|
| Body Fluids | 1 | 2013 | 319 | 0.090 |
Why?
|
| Pandemics | 2 | 2020 | 8611 | 0.090 |
Why?
|
| Periodicals as Topic | 1 | 2021 | 1462 | 0.090 |
Why?
|
| Laryngoscopes | 1 | 2011 | 146 | 0.090 |
Why?
|
| Intracranial Arteriovenous Malformations | 1 | 2013 | 366 | 0.080 |
Why?
|
| Hypersensitivity, Immediate | 1 | 2012 | 345 | 0.080 |
Why?
|
| Physics | 1 | 2010 | 90 | 0.080 |
Why?
|
| Drug Administration Schedule | 1 | 2017 | 4839 | 0.080 |
Why?
|
| Prospective Studies | 8 | 2021 | 54136 | 0.080 |
Why?
|
| Plant Extracts | 1 | 2012 | 489 | 0.080 |
Why?
|
| ROC Curve | 3 | 2023 | 3563 | 0.080 |
Why?
|
| Ambulatory Care | 1 | 2019 | 2768 | 0.080 |
Why?
|
| Hypoglycemia | 1 | 2016 | 881 | 0.080 |
Why?
|
| Hemostasis, Surgical | 1 | 2009 | 127 | 0.080 |
Why?
|
| Biopsy | 1 | 2020 | 6768 | 0.080 |
Why?
|
| Asymptomatic Diseases | 1 | 2011 | 584 | 0.080 |
Why?
|
| Spinal Diseases | 1 | 2013 | 559 | 0.080 |
Why?
|
| Neurofibromatosis 1 | 1 | 2013 | 560 | 0.080 |
Why?
|
| Embryonic Stem Cells | 1 | 2015 | 1262 | 0.070 |
Why?
|
| Histamine H2 Antagonists | 1 | 2009 | 165 | 0.070 |
Why?
|
| Snake Venoms | 1 | 2007 | 40 | 0.070 |
Why?
|
| Drug Therapy, Combination | 1 | 2017 | 6293 | 0.070 |
Why?
|
| Laser Coagulation | 1 | 2009 | 329 | 0.070 |
Why?
|
| Health Status | 1 | 2019 | 4069 | 0.070 |
Why?
|
| Magnetic Resonance Angiography | 1 | 2013 | 1431 | 0.070 |
Why?
|
| Treatment Failure | 1 | 2012 | 2640 | 0.070 |
Why?
|
| Reagent Kits, Diagnostic | 1 | 2007 | 238 | 0.070 |
Why?
|
| Homeodomain Proteins | 1 | 2015 | 2413 | 0.060 |
Why?
|
| Models, Theoretical | 2 | 2010 | 3561 | 0.060 |
Why?
|
| Neurons | 1 | 2005 | 9418 | 0.060 |
Why?
|
| Light | 1 | 2011 | 1345 | 0.060 |
Why?
|
| Doppler Effect | 1 | 2005 | 12 | 0.060 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2014 | 2057 | 0.060 |
Why?
|
| Oxygen Consumption | 1 | 2011 | 1846 | 0.060 |
Why?
|
| Patient Satisfaction | 1 | 2017 | 3446 | 0.060 |
Why?
|
| Electrosurgery | 1 | 2005 | 51 | 0.060 |
Why?
|
| Allergens | 1 | 2012 | 1402 | 0.060 |
Why?
|
| Glycoproteins | 1 | 2012 | 2205 | 0.060 |
Why?
|
| Rhinitis | 2 | 2019 | 746 | 0.060 |
Why?
|
| Palate, Soft | 1 | 2005 | 100 | 0.060 |
Why?
|
| Animals | 8 | 2020 | 167777 | 0.060 |
Why?
|
| Turbinates | 1 | 2005 | 64 | 0.060 |
Why?
|
| Video Recording | 1 | 2010 | 954 | 0.060 |
Why?
|
| Electrocoagulation | 1 | 2005 | 152 | 0.060 |
Why?
|
| Normal Distribution | 1 | 2005 | 272 | 0.060 |
Why?
|
| Benchmarking | 2 | 2021 | 1042 | 0.060 |
Why?
|
| Physicians | 1 | 2022 | 4581 | 0.060 |
Why?
|
| Laparoscopy | 1 | 2016 | 2147 | 0.060 |
Why?
|
| Analysis of Variance | 1 | 2012 | 6233 | 0.060 |
Why?
|
| Lymphocyte Activation | 1 | 2014 | 5490 | 0.060 |
Why?
|
| Snoring | 1 | 2005 | 206 | 0.050 |
Why?
|
| Embolization, Therapeutic | 1 | 2013 | 1407 | 0.050 |
Why?
|
| Risk Factors | 2 | 2020 | 73806 | 0.050 |
Why?
|
| Electronic Health Records | 1 | 2020 | 4761 | 0.050 |
Why?
|
| Statistics as Topic | 1 | 2009 | 2359 | 0.050 |
Why?
|
| Cerebrovascular Circulation | 1 | 2013 | 2731 | 0.050 |
Why?
|
| Hemodynamics | 1 | 2013 | 4159 | 0.050 |
Why?
|
| Predictive Value of Tests | 1 | 2018 | 15225 | 0.050 |
Why?
|
| Tonsillectomy | 1 | 2005 | 268 | 0.050 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2014 | 4353 | 0.050 |
Why?
|
| Rats | 1 | 2018 | 23681 | 0.050 |
Why?
|
| Heartburn | 1 | 2021 | 67 | 0.050 |
Why?
|
| Software | 2 | 2005 | 4416 | 0.050 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2013 | 4048 | 0.040 |
Why?
|
| Australia | 1 | 2023 | 1235 | 0.040 |
Why?
|
| Eustachian Tube | 1 | 2019 | 96 | 0.040 |
Why?
|
| MicroRNAs | 1 | 2014 | 3783 | 0.040 |
Why?
|
| Young Adult | 4 | 2019 | 58808 | 0.040 |
Why?
|
| Equipment Design | 1 | 2006 | 3507 | 0.040 |
Why?
|
| Ear Diseases | 1 | 2019 | 177 | 0.040 |
Why?
|
| Cell Differentiation | 1 | 2015 | 11471 | 0.040 |
Why?
|
| Nasal Obstruction | 1 | 2019 | 159 | 0.040 |
Why?
|
| Chronic Disease | 2 | 2019 | 9266 | 0.040 |
Why?
|
| Technology | 1 | 2020 | 292 | 0.040 |
Why?
|
| Cough | 1 | 2021 | 594 | 0.040 |
Why?
|
| Behavior Therapy | 1 | 2022 | 869 | 0.030 |
Why?
|
| Area Under Curve | 1 | 2019 | 1632 | 0.030 |
Why?
|
| Frizzled Receptors | 1 | 2015 | 90 | 0.030 |
Why?
|
| Reference Values | 2 | 2011 | 4919 | 0.030 |
Why?
|
| Patient Education as Topic | 1 | 2024 | 2307 | 0.030 |
Why?
|
| Prevalence | 2 | 2021 | 15646 | 0.030 |
Why?
|
| Adolescent | 4 | 2019 | 87888 | 0.030 |
Why?
|
| Documentation | 1 | 2019 | 892 | 0.030 |
Why?
|
| Genes, Neurofibromatosis 1 | 1 | 2013 | 74 | 0.030 |
Why?
|
| Child | 3 | 2019 | 79813 | 0.030 |
Why?
|
| Ribonuclease III | 1 | 2014 | 279 | 0.030 |
Why?
|
| Hearing Loss | 1 | 2019 | 780 | 0.030 |
Why?
|
| Ions | 1 | 2013 | 256 | 0.030 |
Why?
|
| Sleep Apnea, Obstructive | 1 | 2005 | 1852 | 0.020 |
Why?
|
| Cerebral Veins | 1 | 2013 | 157 | 0.020 |
Why?
|
| Catheter Ablation | 1 | 2005 | 2740 | 0.020 |
Why?
|
| Wnt Proteins | 1 | 2015 | 719 | 0.020 |
Why?
|
| Child, Preschool | 2 | 2013 | 42058 | 0.020 |
Why?
|
| Cerebral Arteries | 1 | 2013 | 492 | 0.020 |
Why?
|
| Sinusitis | 1 | 2019 | 990 | 0.020 |
Why?
|
| Chlorides | 1 | 2013 | 663 | 0.020 |
Why?
|
| beta Catenin | 1 | 2015 | 1043 | 0.020 |
Why?
|
| Spectrum Analysis | 1 | 2011 | 451 | 0.020 |
Why?
|
| Sensitivity and Specificity | 2 | 2019 | 14641 | 0.020 |
Why?
|
| Administration, Inhalation | 1 | 2012 | 1153 | 0.020 |
Why?
|
| Artificial Intelligence | 1 | 2024 | 2551 | 0.020 |
Why?
|
| Feasibility Studies | 1 | 2019 | 5199 | 0.020 |
Why?
|
| Societies, Medical | 1 | 2020 | 3891 | 0.020 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2005 | 10146 | 0.020 |
Why?
|
| Sodium | 1 | 2013 | 1588 | 0.020 |
Why?
|
| Infant | 1 | 2010 | 36054 | 0.020 |
Why?
|
| Interleukin-2 | 1 | 2014 | 1888 | 0.020 |
Why?
|
| Statistics, Nonparametric | 1 | 2013 | 2850 | 0.020 |
Why?
|
| Cross-Over Studies | 1 | 2012 | 2048 | 0.020 |
Why?
|
| Electromyography | 1 | 2011 | 1388 | 0.020 |
Why?
|
| Catheterization | 1 | 2011 | 1426 | 0.020 |
Why?
|
| Pain | 1 | 2021 | 5065 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2014 | 2443 | 0.020 |
Why?
|
| Binding Sites | 1 | 2014 | 6036 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2005 | 18125 | 0.020 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 2014 | 2532 | 0.020 |
Why?
|
| Pedigree | 1 | 2013 | 4578 | 0.020 |
Why?
|
| Cross Reactions | 1 | 2007 | 818 | 0.020 |
Why?
|
| Comorbidity | 1 | 2019 | 10495 | 0.020 |
Why?
|
| Clinical Competence | 1 | 2020 | 4775 | 0.020 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2015 | 2895 | 0.010 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2015 | 3602 | 0.010 |
Why?
|
| Clinical Trials as Topic | 1 | 2020 | 7985 | 0.010 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2007 | 1539 | 0.010 |
Why?
|
| Base Sequence | 1 | 2014 | 12436 | 0.010 |
Why?
|
| Phosphorylation | 1 | 2014 | 8297 | 0.010 |
Why?
|
| Practice Guidelines as Topic | 1 | 2020 | 7377 | 0.010 |
Why?
|
| Phenotype | 1 | 2021 | 16534 | 0.010 |
Why?
|
| Mice, Transgenic | 1 | 2014 | 9518 | 0.010 |
Why?
|
| Blood Glucose | 1 | 2016 | 6347 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2015 | 18942 | 0.010 |
Why?
|
| Cross-Sectional Studies | 1 | 2020 | 25953 | 0.010 |
Why?
|
| Double-Blind Method | 1 | 2012 | 12262 | 0.010 |
Why?
|
| Mice | 2 | 2015 | 81107 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 2014 | 11894 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 2007 | 13447 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2007 | 17617 | 0.010 |
Why?
|
| United States | 1 | 2020 | 72140 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2014 | 23341 | 0.010 |
Why?
|
| Mutation | 1 | 2013 | 29915 | 0.000 |
Why?
|
Concepts
(274)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(23)
People in Profiles who have published with this person.
Explore
_
Similar People
(59)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_